Skip to content
Advertisement

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions. The European Medicines Agency regulatory committee announced the results of its review on Friday, April 12, 2024. (AP Photo/David J. Phillip, File)

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions. The European Medicines Agency regulatory committee announced the results of its review on Friday, April 12, 2024. (AP Photo/David J. Phillip, File)

Featured Photo Galleries